These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9625481)

  • 1. Drug-delivery products and the Zydis fast-dissolving dosage form.
    Seager H
    J Pharm Pharmacol; 1998 Apr; 50(4):375-82. PubMed ID: 9625481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
    Clarke A; Johnson ES; Mallard N; Corn TH; Johnston A; Boyce M; Warrington S; MacMahon DG
    J Neural Transm (Vienna); 2003 Nov; 110(11):1257-71. PubMed ID: 14628190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freeze dried ondansetron: first observations with the fast dissolving oral antiemetic Zofran Zydis for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients.
    Lehoczky O; Udvary J; Pulay T
    Neoplasma; 2002; 49(2):126-8. PubMed ID: 12088106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive review on oral disintegrating films.
    Nagaraju T; Gowthami R; Rajashekar M; Sandeep S; Mallesham M; Sathish D; Kumar YS
    Curr Drug Deliv; 2013 Feb; 10(1):96-108. PubMed ID: 22920576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to fast dissolving oral thin film drug delivery systems: a review.
    Kathpalia H; Gupte A
    Curr Drug Deliv; 2013 Dec; 10(6):667-84. PubMed ID: 24274635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast dissolving films: a review.
    Chaturvedi A; Srivastava P; Yadav S; Bansal M; Garg G; Sharma PK
    Curr Drug Deliv; 2011 Jul; 8(4):373-80. PubMed ID: 21453260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.
    Baldi F; Malfertheiner P
    Digestion; 2003; 67(1-2):1-5. PubMed ID: 12743433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on the oral solid rapidly disintegrating dosage form].
    Shen L; Lin X; Xu DS; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):89-92. PubMed ID: 15714807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates.
    Preis M; Grother L; Axe P; Breitkreutz J
    Int J Pharm; 2015 Aug; 491(1-2):8-16. PubMed ID: 26051543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formulation strategies of intraoral dosage forms].
    Kállai N; Sebestyén Z; Szabó B; Simon V; Antal I; Zelkó R
    Acta Pharm Hung; 2012; 82(3):95-103. PubMed ID: 23230648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on mouth dissolving films.
    Dahiya M; Saha S; Shahiwala AF
    Curr Drug Deliv; 2009 Oct; 6(5):469-76. PubMed ID: 19751197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions.
    Boudriau S; Hanzel C; Massicotte J; Sayegh L; Wang J; Lefebvre M
    Drugs R D; 2016 Jun; 16(2):229-38. PubMed ID: 27028750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral dosage forms and drug delivery systems: tablets, oral films, liquid dosage forms, oral bioavailability enhancement.
    Alany R
    Pharm Dev Technol; 2017 Mar; 22(2):137. PubMed ID: 28178908
    [No Abstract]   [Full Text] [Related]  

  • 17. Soft gelatin capsules (softgels).
    Gullapalli RP
    J Pharm Sci; 2010 Oct; 99(10):4107-48. PubMed ID: 20737624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K
    Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study.
    Waters CH; Sethi KD; Hauser RA; Molho E; Bertoni JM;
    Mov Disord; 2004 Apr; 19(4):426-32. PubMed ID: 15077240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage form modification and oral drug delivery in older people.
    Lau ETL; Steadman KJ; Cichero JAY; Nissen LM
    Adv Drug Deliv Rev; 2018 Oct; 135():75-84. PubMed ID: 29660383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.